Litcius/Paper detail

Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors

Abdallah E. Abdallah, Reda R. Mabrouk, Maged Mohammed Saleh Al Ward, Sally I. Eissa, Eslam B. Elkaeed, Ahmed B. M. Mehany, Mariam A. Abo-Saif, Ola A. El-Feky, Mohamed S. Alesawy, Mohamed Ayman El‐Zahabi

2022Journal of Enzyme Inhibition and Medicinal Chemistry58 citationsDOIOpen Access PDF

Abstract

of 253 and 381 nM against HER2 and FGFR, respectively.

Topics & Concepts

SorafenibChemistryApoptosisIC50QuinazolineDocking (animal)PharmacologyLead compoundCancer researchStereochemistryHepatocellular carcinomaIn vitroBiochemistryBiologyMedicineNursingQuinazolinone synthesis and applicationsAngiogenesis and VEGF in CancerHER2/EGFR in Cancer Research
Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors | Litcius